Plasma signals of lung tumor promotion and the ubiquitous challenge of biomarker specificity
Abstract This opinion paper examines a recently reported 14-biomarker plasma panel designed to predict lung cancer development and identify patients who might benefit from preventive canakinumab treatment. While stratifying patients using this panel and clinical risk factors improves the number needed to treat (NNT) fr...